NOVEL CYCLIC BORONATE INHIBITORS OF HCV REPLICATION
Compounds of formula (I) or a salt thereof are provided; wherein R1, R2, R3, R4, R6, R8, R20, R30, Y, Z and n are as defined in the description. Uses of the compounds as medicaments, and in the manufacture of medicaments for treating viral infection, especially HCV infection are also disclosed. The...
Saved in:
Main Authors | , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
09.04.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compounds of formula (I) or a salt thereof are provided; wherein R1, R2, R3, R4, R6, R8, R20, R30, Y, Z and n are as defined in the description. Uses of the compounds as medicaments, and in the manufacture of medicaments for treating viral infection, especially HCV infection are also disclosed. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof.
L'invention concerne des composés de formule (I) ou un sel de ceux-ci ; dans laquelle R1, R2, R3, R4, R6, R8, R20, R30, Y, Z et n sont tels que définis dans la description. Des utilisations des composés comme médicaments, et dans la fabrication de médicaments pour le traitement d'une infection virale, en particulier une infection par le virus de l'hépatite C sont également décrites. L'invention comprend en outre des procédés de préparation de ces composés et formulations pharmaceutiques de ceux-ci. |
---|---|
Bibliography: | Application Number: WO2008US78439 |